Laddar...
The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions
The consensus Immunoscore has a prognostic value that has been confirmed in two randomized phase 3 clinical trials, and it provides a reliable estimate of the recurrence risk in colon cancer. The latest edition of the WHO classification of the Digestive System Tumors introduced for the first time th...
Sparad:
| I publikationen: | Oncoimmunology |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Taylor & Francis
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480815/ https://ncbi.nlm.nih.gov/pubmed/32939329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1812221 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|